Cartesian Therapeutics Announces New Employment Inducement Grants
Cartesian Therapeutics granted inducement stock options for an aggregate of 317,200 shares to five new employees at an exercise price of $6.22 per share. The options vest over a four-year schedule, with a 25% cliff on May 1, 2027, and monthly installments continuing until full vesting on May 1, 2030.
Key figures
- Offering Price
- 6.22
- Shares Offered
- 317200
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.